G/TBT/N/CHN/1380  
1 October 2019  
(19-6316) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  CHINA   
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:  National Medical Products Administration  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
3. Notified under Article 2.9.2 [X], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Glands and 
other organs for org ano-therapeutic uses, dried, whether or not powdered; extracts of 
glands or other organs or of their secretions for organo -therapeutic uses; heparin and its 
salts; other human or animal substances prepared for therapeutic or prophylactic uses, not 
elsewher e specified or included (HS 3001); Human blood; animal blood prepared for 
therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and 
modified immunological products, whether or not obtained by means of biotechnological 
processes; vaccines, toxins, cultures of micro -organisms (excluding yeasts) and similar 
products (HS 3002); Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) 
consisting of two or more constituents which have been mixed together for therapeutic or 
prophyl actic uses, not put up in measured doses or in forms or packings for retail sale (HS 
3003); Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of 
mixed or unmixed products for therapeutic or prophylactic uses, put up in measured dose s 
(including those in the form of transdermal administration systems) or in forms or 
packings for retail sale (HS 3004); Pharmaceutical goods specified in Note 4 to this 
Chapter (HS 3006); Medicaments (ICS 11.120.10)  
5. Title, number of pages and language (s) of the notified document:  Regulations for 
the Supervision and Administration of Drug Trading (Draft for Comments) (22 page(s), in 
Chinese)  
6. Description of content:  This regulation is drafted to strengthen the supervision and 
administration of drug trading, to standardize drug trading activities, and to ensure the 
quality and safety of drugs.  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Protection of human health or safety  
8. Relevant documents:  - 
9. Proposed date of adoption:  To be determined  
Proposed date of entry into force:  To be determined  G/TBT/N/CHN/1380  
 
- 2 - 
 
  10. Final date for comments:  60 days from notification  
11. Texts available from:  National enquiry point [X] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
WTO/TBT National Notification and Enquiry Center of the People's Republic of China  
Tel: +86 10 57954630 / 57954627  
Email: tbt@customs.gov.cn  
https://members.wto.org/crnattachments/2019/TBT/CHN/19_5341_00_x.pdf